Phosphoregulation of twist1 provides a mechanism of cell fate control

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Basic Helix-loop-Helix (bHLH) factors play a significant role in both development and disease. bHLH factors function as protein dimers where two bHLH factors compose an active transcriptional complex. In various species, the bHLH factor Twist has been shown to play critical roles in diverse developmental systems such as mesoderm formation, neurogenesis, myogenesis, and neural crest cell migration and differentiation. Pathologically, Twist1 is a master regulator of epithelial-to-mesenchymal transition (EMT) and is causative of the autosomal-dominant human disease Saethre Chotzen Syndrome (SCS). Given the wide spectrum of Twist1 expression in the developing embryo and the diverse roles it plays within these forming tissues, the question of how Twist1 fills some of these specific roles has been largely unanswered. Recent work has shown that Twist's biological function can be regulated by its partner choice within a given cell. Our work has identified a phosphoregulatory circuit where phosphorylation of key residues within the bHLH domain alters partner affinities for Twist1; and more recently, we show that the DNA binding affinity of the complexes that do form is affected in a cis-element dependent manner. Such perturbations are complex as they not only affect direct transcriptional programs of Twist1, but they indirectly affect the transcriptional outcomes of any bHLH factor that can dimerize with Twist1. Thus, the resulting lineage-restricted cell fate defects are a combination of loss-of-function and gain-of-function events. Relating the observed phenotypes of defective Twist function with this complex regulatory mechanism will add insight into our understanding of the critical functions of this complex transcription factor.

Original languageEnglish
Pages (from-to)2641-2647
Number of pages7
JournalCurrent Medicinal Chemistry
Volume15
Issue number25
DOIs
StatePublished - Oct 2008

Fingerprint

Helix-Loop-Helix Motifs
Acrocephalosyndactylia
Epithelial-Mesenchymal Transition
Muscle Development
Neural Crest
Neurogenesis
Mesoderm
Cell Movement
Cell Differentiation
Transcription Factors
Embryonic Structures
Phosphorylation
Phenotype
DNA
Proteins
Dimers
Tissue
Defects
Networks (circuits)

Keywords

  • BHLH
  • Dimerization
  • DNA binding
  • Limb development
  • Phosphorylation
  • Saethre chotzen syndrome
  • Transcription
  • Twist1

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Phosphoregulation of twist1 provides a mechanism of cell fate control. / Firulli, Anthony; Conway, Simon.

In: Current Medicinal Chemistry, Vol. 15, No. 25, 10.2008, p. 2641-2647.

Research output: Contribution to journalArticle

@article{23c15f68fe964acf810826afabe7099d,
title = "Phosphoregulation of twist1 provides a mechanism of cell fate control",
abstract = "Basic Helix-loop-Helix (bHLH) factors play a significant role in both development and disease. bHLH factors function as protein dimers where two bHLH factors compose an active transcriptional complex. In various species, the bHLH factor Twist has been shown to play critical roles in diverse developmental systems such as mesoderm formation, neurogenesis, myogenesis, and neural crest cell migration and differentiation. Pathologically, Twist1 is a master regulator of epithelial-to-mesenchymal transition (EMT) and is causative of the autosomal-dominant human disease Saethre Chotzen Syndrome (SCS). Given the wide spectrum of Twist1 expression in the developing embryo and the diverse roles it plays within these forming tissues, the question of how Twist1 fills some of these specific roles has been largely unanswered. Recent work has shown that Twist's biological function can be regulated by its partner choice within a given cell. Our work has identified a phosphoregulatory circuit where phosphorylation of key residues within the bHLH domain alters partner affinities for Twist1; and more recently, we show that the DNA binding affinity of the complexes that do form is affected in a cis-element dependent manner. Such perturbations are complex as they not only affect direct transcriptional programs of Twist1, but they indirectly affect the transcriptional outcomes of any bHLH factor that can dimerize with Twist1. Thus, the resulting lineage-restricted cell fate defects are a combination of loss-of-function and gain-of-function events. Relating the observed phenotypes of defective Twist function with this complex regulatory mechanism will add insight into our understanding of the critical functions of this complex transcription factor.",
keywords = "BHLH, Dimerization, DNA binding, Limb development, Phosphorylation, Saethre chotzen syndrome, Transcription, Twist1",
author = "Anthony Firulli and Simon Conway",
year = "2008",
month = "10",
doi = "10.2174/092986708785908987",
language = "English",
volume = "15",
pages = "2641--2647",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "25",

}

TY - JOUR

T1 - Phosphoregulation of twist1 provides a mechanism of cell fate control

AU - Firulli, Anthony

AU - Conway, Simon

PY - 2008/10

Y1 - 2008/10

N2 - Basic Helix-loop-Helix (bHLH) factors play a significant role in both development and disease. bHLH factors function as protein dimers where two bHLH factors compose an active transcriptional complex. In various species, the bHLH factor Twist has been shown to play critical roles in diverse developmental systems such as mesoderm formation, neurogenesis, myogenesis, and neural crest cell migration and differentiation. Pathologically, Twist1 is a master regulator of epithelial-to-mesenchymal transition (EMT) and is causative of the autosomal-dominant human disease Saethre Chotzen Syndrome (SCS). Given the wide spectrum of Twist1 expression in the developing embryo and the diverse roles it plays within these forming tissues, the question of how Twist1 fills some of these specific roles has been largely unanswered. Recent work has shown that Twist's biological function can be regulated by its partner choice within a given cell. Our work has identified a phosphoregulatory circuit where phosphorylation of key residues within the bHLH domain alters partner affinities for Twist1; and more recently, we show that the DNA binding affinity of the complexes that do form is affected in a cis-element dependent manner. Such perturbations are complex as they not only affect direct transcriptional programs of Twist1, but they indirectly affect the transcriptional outcomes of any bHLH factor that can dimerize with Twist1. Thus, the resulting lineage-restricted cell fate defects are a combination of loss-of-function and gain-of-function events. Relating the observed phenotypes of defective Twist function with this complex regulatory mechanism will add insight into our understanding of the critical functions of this complex transcription factor.

AB - Basic Helix-loop-Helix (bHLH) factors play a significant role in both development and disease. bHLH factors function as protein dimers where two bHLH factors compose an active transcriptional complex. In various species, the bHLH factor Twist has been shown to play critical roles in diverse developmental systems such as mesoderm formation, neurogenesis, myogenesis, and neural crest cell migration and differentiation. Pathologically, Twist1 is a master regulator of epithelial-to-mesenchymal transition (EMT) and is causative of the autosomal-dominant human disease Saethre Chotzen Syndrome (SCS). Given the wide spectrum of Twist1 expression in the developing embryo and the diverse roles it plays within these forming tissues, the question of how Twist1 fills some of these specific roles has been largely unanswered. Recent work has shown that Twist's biological function can be regulated by its partner choice within a given cell. Our work has identified a phosphoregulatory circuit where phosphorylation of key residues within the bHLH domain alters partner affinities for Twist1; and more recently, we show that the DNA binding affinity of the complexes that do form is affected in a cis-element dependent manner. Such perturbations are complex as they not only affect direct transcriptional programs of Twist1, but they indirectly affect the transcriptional outcomes of any bHLH factor that can dimerize with Twist1. Thus, the resulting lineage-restricted cell fate defects are a combination of loss-of-function and gain-of-function events. Relating the observed phenotypes of defective Twist function with this complex regulatory mechanism will add insight into our understanding of the critical functions of this complex transcription factor.

KW - BHLH

KW - Dimerization

KW - DNA binding

KW - Limb development

KW - Phosphorylation

KW - Saethre chotzen syndrome

KW - Transcription

KW - Twist1

UR - http://www.scopus.com/inward/record.url?scp=58149237893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149237893&partnerID=8YFLogxK

U2 - 10.2174/092986708785908987

DO - 10.2174/092986708785908987

M3 - Article

VL - 15

SP - 2641

EP - 2647

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 25

ER -